CDTRP 2022 Level Up Research Webinar Supported by: astellas These webinars are designed to inform the CDTRP community on various research topics for health care professionals, researchers, patients, families and donors. Access is open to all and free of charge. Registration is mandatory. Date & time

CDTRP 2022 Level Up Research Webinar Supported by: astellas These webinars are designed to inform the CDTRP community on various research topics for health care professionals, researchers, patients, families and donors. Access is open to all and free of charge. Registration is mandatory. Date & time

CDTRP 2022 Level Up Research Webinar Supported by: astellas These webinars are designed to inform the CDTRP community on various research topics for health care professionals, researchers, patients, families and donors. Access is open to all and free of charge. Registration is mandatory. Date & time

CDTRP 2022 Level Up Research Webinar Supported by: astellas These webinars are designed to inform the CDTRP community on various research topics for health care professionals, researchers, patients, families and donors. Access is open to all and free of charge. Registration is mandatory. Date & time

AABB's Virtual Meeting 2022 will take place November 6-7 to share practice-changing research and updates with the field. The two-day virtual event will feature education sessions, top scientific research, and more. AABB is working to expand this previously planned event. Learning objectives The

The Canadian Apheresis Group (CAG), in conjunction with the Canadian Association of Apheresis Nurses (CAAN) is hosting their annual general meeting (AGM) in person on October 21 – 23, 2022. Registration Registration, including a registration fee, is required to attend this event. To learn more about

Presented by Dr. Waseem Anani Medical Director: Immunohematology Reference Laboratory and Blood Associate Professor (Clinical), University of Utah School of Medicine Learning objectives Describe the clinical history of a typical patient having hemolysis from a drug List the mechanisms of drug

Presented by Dr. Heather VanderMeulen Transfusion Medicine Physician Trainee University of Toronto, Toronto Learning objectives Review the epidemiology and clinical significance of D variants in the perinatal period Summarize the current guidelines available to direct the management of the weak D

Presented by Dr. Nadia Gabarin Transfusion Medicine Physician Trainee McMaster University, Hamilton Learning objectives Review the impact of ABO incompatible platelet transfusions on platelet count increments Discuss the incidence of hemolysis in the context of ABO incompatible platelet transfusions

Presented by Dr. Ahmad Alharbi Transfusion Medicine Physician Trainee McMaster University, Hamilton Learning objectives Review the pathogenesis and definition of IVIG related hemolysis. Identify the incidence and risk factors for IVIG related hemolysis. Recognize the IVIG products with low